PF-05212377 Uses, Dosage, Side Effects and more
PF-05212377 is under investigation in clinical trial NCT01712074 (Study Evaluating Thesafety and Efficacy of PF-05212377 or Placebo in Subjects With Alzheimer's Disease With Existing Neuropsychiatric Symptoms on Donepezil).
| Trade Name | PF-05212377 |
| Generic | PF-05212377 |
| Type | |
| Formula | C18H20N4O2S |
| Weight | Average: 356.44 Monoisotopic: 356.130697074 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
